Torrent Pharma Limited Q4 results show revenue rise from 2481 to 2500 crores, a 0.77% increase in growth. EPS also dropped from ₹8.63 to ₹8.48, down by 1.74%.
First, Let’s Begin with Quarter-on-Quarter Basis:
Torrent Pharma Ltd. shared its Q4 results on Tuesday. They earned 2500 crores in revenue this quarter, but that’s higher than the 2481 crores they made last quarter. The company’s growth increased by 0.77 percent when comparing the two quarters.
In terms of profits, the company’s PAT (Profit After Tax) for this quarter was 287 crores, down from 292 crores in the previous quarter. Their quarter-to-quarter growth declined by 1.71 percent.
The company’s EPS (Earnings Per Share) this quarter is ₹8.48, which is a decrease of 1.74% from the ₹8.63 EPS in the previous quarter.
Also read: ☞ ” Graphite India Q4FY23 Results: Consolidated PAT of Rs 29 Cr “
Now, Let’s Analyze the Results on a Year-over-Year Basis:
The company made a total revenue of 9665 crores this year (2023), which is 11.03 percent higher than last year’s total revenue of 8705 crores.
This year’s PAT (Profit After Tax) is 1245 crores, which is also 60.23% higher than last year’s PAT of 777 crores.
The EPS (Earnings Per Share) for this year is ₹36.79, which is 60.24% more than the EPS of ₹22.96 earned last year.
Torrent Pharma Share Dividend Announcement / Record Date:
The Board of Directors has declared a Final Dividend of ₹8 per Equity Share of Face Value of ₹5 each of the Company (160% of Face Value). Total Dividend for FY23 stood at ₹37 per Equity Share (Interim Dividend of ₹10 per Equity Share)
| Dividend | Record Date |
| ₹8 per Equity Share | 23/06/2023 |
About Torrent Pharma:
Torrent Pharmaceuticals Ltd, an Indian multinational pharmaceutical company, is owned by the Torrent Group and has its headquarters in Ahmedabad. Originally established as Trinity Laboratories Ltd by U.N. Mehta, the company underwent a name change and is now known as Torrent Pharmaceuticals Ltd.
Download the Full PDF of Q4 Results: Click Here
For more of the Latest News, Click Here
One thought on “Torrent Pharma Q4FY23 Results: Consolidated PAT Rose to Rs 287 Cr”